Ladenburg Thalmann Financial Services
http://www.ladenburg.comLadenburg Thalmann Financial Services, Inc. (AMEX: LTS) provides retail and institutional securities brokerage, investment banking, investment activities, and asset management services as well as equity research. In May of 2008, Ladenburg Thalmann acquired Punk Ziegel & Company to strengthen its trading, research, and investment banking departments. Ladenburg Thalmann is headquartered in Miami, FL.
View Older Stories View More Recent Stories
-
C3J Therapeutics and AmpliPhi Biosciences Announce Successful Completion of Merger and Formation of Bacteriophage Company Armata Pharmaceuticals, Inc.
-
Form 10-Q LADENBURG THALMANN FINAN For: Mar 31
-
Ladenburg Reports First Quarter 2019 Financial Results
-
Saratoga Investment Corp. Announces Fiscal Year End and Fourth Quarter 2019 Financial Results
-
Saratoga Investment Corp. Announces Fiscal Year End and Fourth Quarter 2019 Financial Results
-
SRAX to Participate in Upcoming Investor Conferences
-
B. Riley Financial Closes $100 Million Senior Notes Offering including Full Exercise of Over-allotment Option
-
VICI Properties Inc. (VICI) PT Raised to $26 at Ladenburg Thalmann
-
Realty Income (O) Prices 11M Share Common Offering at $69.25/Sh
-
Realty Income Announces Pricing Of 11.0 Million Share Common Stock Offering
-
Realty Income (O) to Offer 11M Shares
-
Digital Turbine to Participate in Upcoming Investor Conferences
-
Realty Income Announces Commencement Of Common Stock Public Offering
-
Yieldmo to Participate in the Ladenburg Thalmann 2019 Technology Expo
-
RADA to Present at Upcoming Investor Conferences
-
Ladenburg Thalmann Downgrades OFS Capital (OFS) to Neutral
-
LivePerson (LPSN) PT Raised to $34 at Ladenburg Thalmann
-
B. Riley Financial Announces Pricing of Senior Notes Offering
-
ShotSpotter Sets May 2019 Financial Conference Schedule
-
B. Riley Financial Announces Offering of $50 Million Senior Notes Due 2024 and “BBB+” Rating from Egan-Jones
-
Ladenburg Thalmann Sends Annual Letter to Shareholders
-
Resonant Inc. to Participate in Upcoming Investor Conferences
-
Ladenburg Thalmann Downgrades Dynex Capital (DX) to Neutral
-
Pitney Bowes (PBI) PT Lowered to $10 at Ladenburg Thalmann
-
Ladenburg Thalmann Upgrades Energous Corp (WATT) to Buy
-
Form DEF 14A LADENBURG THALMANN FINAN For: Apr 30
-
Summit Wireless Technologies to Participate in Four Upcoming Investor Conferences
-
Agree Realty (ADC) Prices 2.75M Share Forward Common Offering at $68.85/Sh
-
Agree Realty Announces Pricing of Forward Common Stock Offering
-
Priority Income Fund Launches AA- Rated Preferred Stock Program
-
Ladenburg Appoints Industry Leader David Ballard To Newly-Created Position Of Senior Vice President, Enterprise Services
-
OptimizeRx to Present at Investor Conferences in May
-
OptimizeRx to Present at Investor Conferences in May
-
UPDATE: Ladenburg Thalmann Starts Immunic Inc. (IMUX) at Buy
-
Securities America Recruits Rochester, N.Y.-Based Producer Group with over $200 Million in Total Client Assets
-
Brainsway Ltd. Announces Closing of Initial Public Offering
-
Brainsway Ltd. Announces Closing of Initial Public Offering
-
Form 4 LADENBURG THALMANN FINAN For: Apr 17 Filed by: Simkin Jacqueline M
-
Greenlane Holdings (GNLN) IPO Opens 70% Higher
-
UPDATE: Greenlane Holdings Inc. (GNLN) Prices 6M Class A Shares at $17/Sh
-
Eiger BioPharmaceuticals (EIGR) Prices 4.5M Share Offering at $11/Sh
-
Greenlane Announces Pricing of Upsized Initial Public Offering
-
Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Brainsway Ltd. (BWAY) Prices 2.5M ADS IPO at $11/ADS
-
Brainsway Ltd. Announces Pricing of Initial Public Offering of 2.5 Million American Depositary Shares
-
PlacementTracker Publishes Q1 2019 PIPE and Private Placement Markets League Tables
-
Form 4 LADENBURG THALMANN FINAN For: Apr 15 Filed by: Malamed Adam Scott
-
Form 4 LADENBURG THALMANN FINAN For: Apr 15 Filed by: LAMPEN RICHARD
-
Form 4 LADENBURG THALMANN FINAN For: Apr 12 Filed by: Malamed Adam Scott
-
Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory and Autoimmune Diseases

